Olatosi O O, Sote E O, Orenuga O O
Department of Child Dental Health, Faculty of Dental Sciences, College of Medicine, University of Lagos, Lagos, Nigeria.
Niger J Clin Pract. 2015 Mar-Apr;18(2):292-6. doi: 10.4103/1119-3077.151071.
Pulpotomy is the common therapy for cariously exposed pulps in symptom-free primary molar teeth. Formocresol (FC) is considered the gold standard dressing agent for pulpotomy, but concerns have been raised over the years about its safety. Other alternative pulpotomy agents have been investigated and suggested.
The objective was to evaluate and compare the clinical and radiographic response of FC and white mineral trioxide aggregate (MTA) as pulpotomy materials on primary molars.
Fifty primary molars, with deep carious lesion that exposed a vital but asymptomatic pulp, in 37 children aged 4-7 years were treated with conventional pulpotomy procedure. The teeth were divided randomly into two groups. Group I (FC) and group II (MTA). The treated teeth were evaluated clinically and radiographically and were followed-up for 12 months.
At the end of the 12 months follow-up, the clinical success rates for FC and MTA were 81% and 100%, respectively. There was a statistically significant difference ( P = 0.04) between the clinical success rates of FC and MTA. While the radiographic success rates for FC and MTA were 81% and 96%, respectively, there was no statistically significant difference between the radiographic success of MTA and FC.
White MTA showed a higher clinical and radiographic success rate when compared to FC as a pulpotomy agent in vital primary molars, and it has a potential to become a replacement for FC in primary molars.
牙髓切断术是无症状的乳磨牙龋源性露髓的常用治疗方法。甲醛甲酚(FC)被认为是牙髓切断术的金标准敷料剂,但多年来人们对其安全性一直存在担忧。已对其他替代牙髓切断术药物进行了研究和推荐。
评估和比较FC与白色矿物三氧化物聚合体(MTA)作为乳磨牙牙髓切断术材料的临床和影像学反应。
对37名4 - 7岁儿童的50颗患有深龋病变且暴露有活力但无症状牙髓的乳磨牙进行常规牙髓切断术治疗。将牙齿随机分为两组。第一组(FC)和第二组(MTA)。对治疗后的牙齿进行临床和影像学评估,并随访12个月。
在12个月的随访结束时,FC和MTA的临床成功率分别为81%和100%。FC和MTA的临床成功率之间存在统计学显著差异(P = 0.04)。而FC和MTA的影像学成功率分别为81%和96%,MTA和FC的影像学成功率之间无统计学显著差异。
在有活力的乳磨牙中,与FC作为牙髓切断术药物相比,白色MTA显示出更高的临床和影像学成功率,并且它有可能成为乳磨牙中FC的替代品。